Vitiligo. Vitiligo
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with persistent vitiligo are resistant to medical treatment, ie they have not had a new lesion in the past year and their previous lesions have not become larger. Patients should be between 13 and 65 years old Patients must give informed consent Patients should be willing to cooperate during the study and follow-up period.
Exclusion criteria
Exclusion criteria: Patients with immunodeficiency atients with bleeding disorders Patients being treated for other illnesses
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Having Complaints. Timepoint: 2 and 4 months after treatment. Method of measurement: questionnaire- visual analog scale (VAS).;Improvement Score. Timepoint: 2 and 4 months after treatment. Method of measurement: questionnaire-visual analog scale (VAS).;Satisfaction Score. Timepoint: 2 and 4 months after treatment. Method of measurement: questionnaire -visual analog scale (VAS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Esfahan University of Medical Sciences